Bis-aminooxy-PEG3, 1g

3-Bromo-5-methoxyaniline, 95.0%, 100g

N-Benzoylmeroquinene tert-Butyl Ester>98.0%(N)1g

Ethyl 3-bromo-4-fluorobenzoate, 95.0%, 500g

6-Chloro-2-morpholinonicotinic acid, 97%, 1g

Oxion Inverso OX.2003-PLPH with LWD Plan phase 10x/20x/40x objectives

2,5-Dioxopyrrolidin-1-yl 2-(4-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)phenyl)acetate, 98%, 1g

2-imino-4-oxo-1,3-thiazinane-6-carboxylic acid, 95.0%, 1g

(2E)-3-(2,4-dichlorophenyl)-1-(2,5-dimethoxyphenyl)prop-2-en-1-one, 95.0%, 2g

2-Oxo-2,3-dihydro-1,3-benzoxazole-7-carboxylic acid, 98%, 1g

LASOFOXIFENE TARTRATE, 98%, 10mg

1-(Methylcarbamoyl)cyclobutane-1-carboxylic acid, 98%, 1g

5-Amino-1-N-methylindole, 97.0%, 10g